THORATEC LABORATORIES CORP
10-Q, EX-27, 2000-11-14
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: THORATEC LABORATORIES CORP, 10-Q, 2000-11-14
Next: CITIZENS BANKING CORP, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE BALANCE
SHEETS, STATEMENTS OF OPERATIONS AND STATEMENTS OF CASH FLOWS OF THORATEC
LABORATORIES CORPORATION AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES & EXCHANGE
ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2000.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-30-2000
<PERIOD-START>                             JAN-02-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                       5,853,437
<SECURITIES>                                12,444,164
<RECEIVABLES>                                4,931,223
<ALLOWANCES>                                         0
<INVENTORY>                                  8,920,237
<CURRENT-ASSETS>                            32,650,122
<PP&E>                                       9,123,751
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                              42,837,562
<CURRENT-LIABILITIES>                        6,045,030
<BONDS>                                              0
                                0
                                          0
<COMMON>                                    89,749,996
<OTHER-SE>                                (53,598,185)
<TOTAL-LIABILITY-AND-EQUITY>                42,837,562
<SALES>                                      6,194,459
<TOTAL-REVENUES>                             6,537,706
<CGS>                                        2,221,327
<TOTAL-COSTS>                                2,221,327
<OTHER-EXPENSES>                             6,183,147
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (1,866,768)
<INCOME-TAX>                                     2,487
<INCOME-CONTINUING>                        (1,869,255)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,869,255)
<EPS-BASIC>                                   (0.08)
<EPS-DILUTED>                                   (0.08)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission